84 related articles for article (PubMed ID: 14737662)
1. Cyclic PNA-based compound directed against HIV-1 TAR RNA: modelling, liquid-phase synthesis and TAR binding.
Depecker G; Patino N; Di Giorgio C; Terreux R; Cabrol-Bass D; Bailly C; Aubertin AM; Condom R
Org Biomol Chem; 2004 Jan; 2(1):74-9. PubMed ID: 14737662
[TBL] [Abstract][Full Text] [Related]
2. In vitro selection of RNA aptamers derived from a genomic human library against the TAR RNA element of HIV-1.
Watrin M; Von Pelchrzim F; Dausse E; Schroeder R; Toulmé JJ
Biochemistry; 2009 Jul; 48(26):6278-84. PubMed ID: 19496624
[TBL] [Abstract][Full Text] [Related]
3. Binding of a dinuclear ruthenium(ii) complex to the TAR region of the HIV-AIDS viral RNA.
Buck DP; Spillane CB; Collins JG; Keene FR
Mol Biosyst; 2008 Aug; 4(8):851-4. PubMed ID: 18633486
[TBL] [Abstract][Full Text] [Related]
4. Solid-phase synthesis and thermal denaturation study of cyclic PNAs targeting the HIV-1 TAR RNA loop.
Upert G; Mehiri M; Di Giorgio A; Condom R; Patino N
Bioorg Med Chem Lett; 2007 Nov; 17(21):6026-30. PubMed ID: 17826994
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic studies of mini-TAR RNA/DNA annealing in the absence and presence of HIV-1 nucleocapsid protein.
Vo MN; Barany G; Rouzina I; Musier-Forsyth K
J Mol Biol; 2006 Oct; 363(1):244-61. PubMed ID: 16962137
[TBL] [Abstract][Full Text] [Related]
6. Polyamide amino acids trimers as TAR RNA ligands and anti-HIV agents.
Bonnard V; Pascale L; Azoulay S; Di Giorgio A; Rogez-Kreuz C; Storck K; Clayette P; Patino N
Bioorg Med Chem; 2010 Nov; 18(21):7432-8. PubMed ID: 20889349
[TBL] [Abstract][Full Text] [Related]
7. Interaction of new PNA-based molecules with TAR RNA of HIV-1: molecular modelling and biological evaluation.
Terreux R; Pairot S; Cabrol-Bass D; Patino N; Condom R
J Mol Graph Model; 2001; 19(6):579-85, 614-5. PubMed ID: 11552687
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
[TBL] [Abstract][Full Text] [Related]
9. Hexitol nucleic acid-containing aptamers are efficient ligands of HIV-1 TAR RNA.
Kolb G; Reigadas S; Boiziau C; van Aerschot A; Arzumanov A; Gait MJ; Herdewijn P; Toulmé JJ
Biochemistry; 2005 Mar; 44(8):2926-33. PubMed ID: 15723535
[TBL] [Abstract][Full Text] [Related]
10. Bimodal loop-loop interactions increase the affinity of RNA aptamers for HIV-1 RNA structures.
Boucard D; Toulmé JJ; Di Primo C
Biochemistry; 2006 Feb; 45(5):1518-24. PubMed ID: 16445294
[TBL] [Abstract][Full Text] [Related]
11. A cyclic PNA-based compound targeting domain IV of HCV IRES RNA inhibits in vitro IRES-dependent translation.
Caldarelli SA; Mehiri M; Di Giorgio A; Martin A; Hantz O; Zoulim F; Terreux R; Condom R; Patino N
Bioorg Med Chem; 2005 Oct; 13(20):5700-9. PubMed ID: 16061387
[TBL] [Abstract][Full Text] [Related]
12. Slight sequence modifications unexpectedly alter the metal-dependency of a kissing-loop interaction.
Ohuchi SP; Nakamura Y
Nucleic Acids Symp Ser (Oxf); 2007; (51):395-6. PubMed ID: 18029753
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA.
Mayer M; Lang PT; Gerber S; Madrid PB; Pinto IG; Guy RK; James TL
Chem Biol; 2006 Sep; 13(9):993-1000. PubMed ID: 16984889
[TBL] [Abstract][Full Text] [Related]
14. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA.
Henriet S; Richer D; Bernacchi S; Decroly E; Vigne R; Ehresmann B; Ehresmann C; Paillart JC; Marquet R
J Mol Biol; 2005 Nov; 354(1):55-72. PubMed ID: 16236319
[TBL] [Abstract][Full Text] [Related]
15. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
[TBL] [Abstract][Full Text] [Related]
16. Base flexibility in HIV-2 TAR RNA mapped by solution (15)N, (13)C NMR relaxation.
Dayie KT; Brodsky AS; Williamson JR
J Mol Biol; 2002 Mar; 317(2):263-78. PubMed ID: 11902842
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cellular uptake of a fluorescently labeled cyclic PNA-based compound.
Caldarelli S; Depecker G; Patino N; Di Giorgio A; Barouillet T; Doglio A; Condom R
Bioorg Med Chem Lett; 2004 Sep; 14(17):4435-8. PubMed ID: 15357967
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and bioactivities of TAR RNA targeting beta-carboline derivatives based on Tat-TAR interaction.
Yu X; Lin W; Pang R; Yang M
Eur J Med Chem; 2005 Sep; 40(9):831-9. PubMed ID: 15925430
[TBL] [Abstract][Full Text] [Related]
19. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
Riguet E; Tripathi S; Chaubey B; Désiré J; Pandey VN; Décout JL
J Med Chem; 2004 Sep; 47(20):4806-9. PubMed ID: 15369382
[TBL] [Abstract][Full Text] [Related]
20. Spirocyclic helical compounds as binding agents for bulged RNA, including HIV-2 TAR.
Xiao Z; Zhang N; Lin Y; Jones GB; Goldberg IH
Chem Commun (Camb); 2006 Nov; (42):4431-3. PubMed ID: 17057867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
